These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30796888)

  • 1. Early use of polymyxin B reduces the mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection.
    Liang Q; Huang M; Xu Z
    Braz J Infect Dis; 2019; 23(1):60-65. PubMed ID: 30796888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colistin versus polymyxin B for the treatment of carbapenem-resistant Klebsiella pneumoniae bloodstream infections.
    Vieceli T; Henrique LR; Rech TH; Zavascki AP
    J Infect Chemother; 2024 Jul; 30(7):621-625. PubMed ID: 38244722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with polymyxin B for carbapenemase-producing Klebsiella pneumoniae bloodstream infection.
    Medeiros GS; Rigatto MH; Falci DR; Zavascki AP
    Int J Antimicrob Agents; 2019 Feb; 53(2):152-157. PubMed ID: 30722960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The efficacy and safety of different antimicrobial regimens in carbapenem-resistant
    Sun WM; Zhou H; Shen LS; Yang Q; Ma WJ; Zhou JY
    Zhonghua Nei Ke Za Zhi; 2019 Aug; 58(8):566-571. PubMed ID: 31365977
    [No Abstract]   [Full Text] [Related]  

  • 5. Bloodstream Infections due to Carbapenem-Resistant
    Shen L; Lian C; Zhu B; Yao Y; Yang Q; Zhou J; Zhou H
    Microb Drug Resist; 2021 Feb; 27(2):227-233. PubMed ID: 32584202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose tigecycline for the treatment of nosocomial carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A retrospective cohort study.
    Geng TT; Xu X; Huang M
    Medicine (Baltimore); 2018 Feb; 97(8):e9961. PubMed ID: 29465589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae.
    Tian Y; Zhang Q; Wen L; Chen J
    Microbiol Spectr; 2021 Oct; 9(2):e0015221. PubMed ID: 34704782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of carbapenem-resistant
    Wang Y; Lei H; Zhang Y; Yang Q; Wang Y; Wang J; Xu C; Yu J; Zhou L; Kang X; Cui L
    Antimicrob Resist Infect Control; 2018; 7():66. PubMed ID: 29942492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and mortality for patients with Bloodstream infections of Klebsiella pneumoniae during 2014-2018: Clinical impact of carbapenem resistance in a large tertiary hospital of China.
    Chang H; Wei J; Zhou W; Yan X; Cao X; Zuo L; Chen S; Yao K; Huang R; Chen Y; Wu C
    J Infect Public Health; 2020 May; 13(5):784-790. PubMed ID: 31843651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TDM-guided medication of polymyxin B in a patient with CRKP-induced bloodstream infection: a case report.
    Yu X; Pan J; Zhou Z; Wen X; Dai Y; Lin G; Jiao Z; Zhang C
    Eur J Clin Microbiol Infect Dis; 2021 Jan; 40(1):201-204. PubMed ID: 32661810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Outcome of Bacteremia Due to Non-Carbapenemase-producing Carbapenem-Resistant Klebsiella pneumoniae Bacteremia: Role of Carbapenem Combination Therapy.
    Lee NY; Tsai CS; Syue LS; Chen PL; Li CW; Li MC; Ko WC
    Clin Ther; 2020 Mar; 42(3):e33-e44. PubMed ID: 32061374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections.
    Gomez-Simmonds A; Nelson B; Eiras DP; Loo A; Jenkins SG; Whittier S; Calfee DP; Satlin MJ; Kubin CJ; Furuya EY
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3601-7. PubMed ID: 27044555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of cefepime breakpoint in patients with carbapenem-resistant Klebsiella pneumoniae bacteraemia.
    Lee NY; Lo CL; Chen PL; Syue LS; Li CW; Li MC; Ko WC
    Int J Antimicrob Agents; 2021 Feb; 57(2):106250. PubMed ID: 33264671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for treatment failure of polymyxin B monotherapy for carbapenem-resistant Klebsiella pneumoniae infections.
    Dubrovskaya Y; Chen TY; Scipione MR; Esaian D; Phillips MS; Papadopoulos J; Mehta SA
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5394-7. PubMed ID: 23959321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Retrospective Analysis of Risk Factors and Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in Nontransplant Patients.
    Xiao T; Zhu Y; Zhang S; Wang Y; Shen P; Zhou Y; Yu X; Xiao Y
    J Infect Dis; 2020 Mar; 221(Suppl 2):S174-S183. PubMed ID: 32176799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network.
    Zhang Y; Wang Q; Yin Y; Chen H; Jin L; Gu B; Xie L; Yang C; Ma X; Li H; Li W; Zhang X; Liao K; Man S; Wang S; Wen H; Li B; Guo Z; Tian J; Pei F; Liu L; Zhang L; Zou C; Hu T; Cai J; Yang H; Huang J; Jia X; Huang W; Cao B; Wang H
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection.
    Giannella M; Trecarichi EM; Giacobbe DR; De Rosa FG; Bassetti M; Bartoloni A; Bartoletti M; Losito AR; Del Bono V; Corcione S; Tedeschi S; Raffaelli F; Saffioti C; Spanu T; Rossolini GM; Marchese A; Ambretti S; Cauda R; Viscoli C; Lewis RE; Viale P; Tumbarello M;
    Int J Antimicrob Agents; 2018 Feb; 51(2):244-248. PubMed ID: 28842283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review.
    Jacobs DM; Safir MC; Huang D; Minhaj F; Parker A; Rao GG
    Ann Clin Microbiol Antimicrob; 2017 Nov; 16(1):76. PubMed ID: 29178957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter Genomic Analysis of Carbapenem-Resistant Klebsiella pneumoniae from Bacteremia in China.
    Cienfuegos-Gallet AV; Zhou Y; Ai W; Kreiswirth BN; Yu F; Chen L
    Microbiol Spectr; 2022 Apr; 10(2):e0229021. PubMed ID: 35230130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staggering the administration of polymyxin B and meropenem in time-kill against carbapenem-resistant Enterobacteriaceae exhibiting a wide range of meropenem MICs.
    Kulengowski B; Clark JA; Burgess DS
    Diagn Microbiol Infect Dis; 2019 Mar; 93(3):261-264. PubMed ID: 30344066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.